Humanity Protocol’s Terence Kwok said some multisig keys may have been accidentally backed up to a compromised device during setup.

Latest NewsRead More

You might also be interested in reading Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC.